135 related articles for article (PubMed ID: 38713098)
41. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
42. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.
Qiu AW; Liu QH; Wang JL
Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445
[TBL] [Abstract][Full Text] [Related]
43. TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice.
Orduña Ríos M; Noguez Imm R; Hernández Godínez NM; Bautista Cortes AM; López Escalante DD; Liedtke W; Martínez Torres A; Concha L; Thébault S
PLoS One; 2019; 14(5):e0212158. PubMed ID: 31048895
[TBL] [Abstract][Full Text] [Related]
44. Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes.
Tonade D; Liu H; Palczewski K; Kern TS
Diabetologia; 2017 Oct; 60(10):2111-2120. PubMed ID: 28755268
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
46. Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.
Alrashdi SF; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2018 Nov; 176():1-9. PubMed ID: 29944850
[TBL] [Abstract][Full Text] [Related]
47. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex.
Sheu WH; Lin KH; Wang JS; Lai DW; Lee WJ; Lin FY; Chen PH; Chen CH; Yeh HY; Wu SM; Shen CC; Lee MR; Liu SH; Sheu ML
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e46-e62. PubMed ID: 33176446
[TBL] [Abstract][Full Text] [Related]
49. Protective effects of methane-rich saline on diabetic retinopathy via anti-inflammation in a streptozotocin-induced diabetic rat model.
Wu J; Wang R; Ye Z; Sun X; Chen Z; Xia F; Sun Q; Liu L
Biochem Biophys Res Commun; 2015 Oct; 466(2):155-61. PubMed ID: 26363454
[TBL] [Abstract][Full Text] [Related]
50. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.
Canning P; Kenny BA; Prise V; Glenn J; Sarker MH; Hudson N; Brandt M; Lopez FJ; Gale D; Luthert PJ; Adamson P; Turowski P; Stitt AW
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7213-8. PubMed ID: 27298369
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
Maugeri G; D'Amico AG; Bucolo C; D'Agata V
Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
[TBL] [Abstract][Full Text] [Related]
52. Basigin can be a therapeutic target to restore the retinal vascular barrier function in the mouse model of diabetic retinopathy.
Arima M; Cui D; Kimura T; Sonoda KH; Ishibashi T; Matsuda S; Ikeda E
Sci Rep; 2016 Dec; 6():38445. PubMed ID: 27917946
[TBL] [Abstract][Full Text] [Related]
53. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
[TBL] [Abstract][Full Text] [Related]
54. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
[TBL] [Abstract][Full Text] [Related]
55. Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.
Chung YR; Choi JA; Koh JY; Yoon YH
J Diabetes Res; 2017; 2017():1763292. PubMed ID: 28127564
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
Wang L; Wang N; Tan HY; Zhang Y; Feng Y
J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
[TBL] [Abstract][Full Text] [Related]
57. [The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats].
Dong M; Zhang W; Chen S; Wang JM; Duan HT; Kong JH; Wang YX; Bi X; Song J
Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):53-58. PubMed ID: 28162200
[No Abstract] [Full Text] [Related]
58. Tumor necrosis factor ligand-related molecule 1A maintains blood-retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy.
Li J; Xie R; Jiang F; Li Y; Zhu Y; Liu Z; Liao M; Liu Y; Meng X; Chen S; Yu J; Du M; Wang X; Chen Y; Yan H
FASEB J; 2021 Nov; 35(11):e22008. PubMed ID: 34679191
[TBL] [Abstract][Full Text] [Related]
59. MEK/ERK/RUNX2 Pathway-Mediated IL-11 Autocrine Promotes the Activation of Müller Glial Cells during Diabetic Retinopathy.
Ji N; Guo Y; Liu S; Zhu M; Tu Y; Du J; Wang X; Wang Y; Song E
Curr Eye Res; 2022 Dec; 47(12):1622-1630. PubMed ID: 36154781
[TBL] [Abstract][Full Text] [Related]
60. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
